On October 24, Novartis released its 2023 Q3 financial report. The global net sales for the first nine months were $34.017 billion, representing a year-on-year increase of 10%. The global net sales for the third quarter were $11.782 billion, marking a year-on-year growth of 12%, primarily driven by Kesimpta.(Ofatumumab)、Entresto(Sacubitril Valsartan Sodium)、Kisqali(Ribociclib)The continued strong performance of Pluvicto and Scemblix drove revenue growth. Notably, net sales in China for the third quarter were $848 million, representing a 14% increase year-over-year.Based on the performance in the first three quarters, Novartis has raised its full-year forecast, expecting global net sales to achieve high single-digit growth.
Specifically, Entresto's revenue in the first nine months was $4.40 billion, representing a 33% year-over-year increase.Sales in the third quarter were $1.485 billion, a year-on-year increase of 31%.Cosentyx Revenue in the First 9 Months Reached $3.677 Billion, a Year-on-Year Increase of 1%; Q3 Sales Were $1.329 Billion, a Year-on-Year Increase of 4%.Kesimpta's revenue in the first 9 months was $1.53 billion, a year-on-year increase of 112%; the sales in the third quarter were $657 million, a year-on-year increase of 124%.Kisqali's revenue in the first nine months was $1.47 billion, a year-on-year increase of 74%; the sales in the third quarter were $562 million, a year-on-year increase of 76%.Copyright © 2023 PHARMCUBE. All Rights Reserved.
Welcome to forward, share, and reasonably cite. When citing, please clearly indicate the source of the article in a prominent position;For reprint, please leave a message or send a message to the WeChat Official Account backend, and indicate the name and ID of the official account.
Disclaimer: The information in this WeChat article is for general reference only and should not be used directly as decision-making content. PharmaCube assumes no responsibility for any loss incurred by any party due to the use of the content herein.
Online Live Streaming & Offline Salon
↑ Long PressScan the code, Schedule Live ↑
